Literature DB >> 19114897

C1-inhibitor attenuates neurobehavioral deficits and reduces contusion volume after controlled cortical impact brain injury in mice.

Luca Longhi1, Carlo Perego, Fabrizio Ortolano, Elisa R Zanier, Paolo Bianchi, Nino Stocchetti, Tracy K McIntosh, Maria Grazia De Simoni.   

Abstract

OBJECTIVE: The aim of the study was to evaluate the effects of C1-inhibitor (C1-INH), an endogenous inhibitor of complement and kinin systems, on neurobehavioral and histological outcome following controlled cortical impact brain injury.
DESIGN: Experimental prospective randomized study in mice.
SETTING: Experimental laboratory.
SUBJECTS: Male C57Bl/6 mice (n = 81).
INTERVENTIONS: Mice were subjected to controlled cortical impact brain injury followed by an intravenous bolus of either C1-INH (15 U either at 10 minutes or 1 hour postinjury) or saline (equal volume, 150 microl at 10 minutes postinjury). Sham-operated mice received identical surgery and saline injection without brain injury. Neurological motor function was evaluated weekly for 4 weeks using the Composite Neuroscore. Cognitive function was evaluated at 4 weeks postinjury using the Morris Water Maze. Histological outcome was performed by measuring the contusion volume at 1 week and 4 weeks postinjury.
MEASUREMENTS AND MAIN RESULTS: Brain-injured mice receiving C1-INH at 10 minutes postinjury showed attenuated motor deficits, cognitive dysfunction and reduced contusion volume compared to brain-injured mice receiving saline. Mice receiving C1-INH at 1 hour postinjury showed reduced motor deficits compared to brain-injured mice receiving saline, but no significantly different cognitive and histological outcome. Immunohistochemical analysis showed that 20 minutes after infusion, C1-INH was localised on endothelial cells and in brain tissue surrounding brain capillaries of the injured hemisphere.
CONCLUSION: Our results show that post-traumatic administration of C1-INH attenuates neuro-behavioral deficits and histological damage associated with traumatic brain injury.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19114897     DOI: 10.1097/CCM.0b013e318195998a

Source DB:  PubMed          Journal:  Crit Care Med        ISSN: 0090-3493            Impact factor:   7.598


  39 in total

Review 1.  The role of inflammation in epilepsy.

Authors:  Annamaria Vezzani; Jacqueline French; Tamas Bartfai; Tallie Z Baram
Journal:  Nat Rev Neurol       Date:  2010-12-07       Impact factor: 42.937

2.  Vasopressin amplifies the production of proinflammatory mediators in traumatic brain injury.

Authors:  Joanna Szmydynger-Chodobska; Leora M Fox; Kirsten M Lynch; Brian J Zink; Adam Chodobski
Journal:  J Neurotrauma       Date:  2010-08       Impact factor: 5.269

Review 3.  What has inflammation to do with traumatic brain injury?

Authors:  David Cederberg; Peter Siesjö
Journal:  Childs Nerv Syst       Date:  2009-11-26       Impact factor: 1.475

4.  Pharmacological inhibition of mannose-binding lectin ameliorates neurobehavioral dysfunction following experimental traumatic brain injury.

Authors:  Daiana De Blasio; Stefano Fumagalli; Luca Longhi; Franca Orsini; Alessandro Palmioli; Matteo Stravalaci; Gloria Vegliante; Elisa R Zanier; Anna Bernardi; Marco Gobbi; Maria-Grazia De Simoni
Journal:  J Cereb Blood Flow Metab       Date:  2016-07-20       Impact factor: 6.200

5.  Complement C3 Inhibition Modulates Neurodegeneration in Chronic Traumatic Brain Injury.

Authors:  Mary Ellene Boulos; Michael Johnathan Charles Bray
Journal:  J Neurosci       Date:  2018-08-15       Impact factor: 6.167

6.  Fractalkine Receptor Deficiency Is Associated with Early Protection but Late Worsening of Outcome following Brain Trauma in Mice.

Authors:  Elisa R Zanier; Federica Marchesi; Fabrizio Ortolano; Carlo Perego; Maedeh Arabian; Tommaso Zoerle; Eliana Sammali; Francesca Pischiutta; Maria-Grazia De Simoni
Journal:  J Neurotrauma       Date:  2015-09-08       Impact factor: 5.269

7.  Targeting mannose-binding lectin confers long-lasting protection with a surprisingly wide therapeutic window in cerebral ischemia.

Authors:  Franca Orsini; Pia Villa; Sara Parrella; Rosalia Zangari; Elisa R Zanier; Raffaella Gesuete; Matteo Stravalaci; Stefano Fumagalli; Roberta Ottria; José J Reina; Alessandra Paladini; Edoardo Micotti; Renato Ribeiro-Viana; Javier Rojo; Vasile I Pavlov; Gregory L Stahl; Anna Bernardi; Marco Gobbi; Maria-Grazia De Simoni
Journal:  Circulation       Date:  2012-08-09       Impact factor: 29.690

8.  An anticomplement agent that homes to the damaged brain and promotes recovery after traumatic brain injury in mice.

Authors:  Marieta M Ruseva; Valeria Ramaglia; B Paul Morgan; Claire L Harris
Journal:  Proc Natl Acad Sci U S A       Date:  2015-11-02       Impact factor: 11.205

9.  Tumor necrosis factor in traumatic brain injury: effects of genetic deletion of p55 or p75 receptor.

Authors:  Luca Longhi; Carlo Perego; Fabrizio Ortolano; Silvia Aresi; Stefano Fumagalli; Elisa R Zanier; Nino Stocchetti; Maria-Grazia De Simoni
Journal:  J Cereb Blood Flow Metab       Date:  2013-04-24       Impact factor: 6.200

10.  Bone marrow mesenchymal stromal cells drive protective M2 microglia polarization after brain trauma.

Authors:  Elisa R Zanier; Francesca Pischiutta; Loredana Riganti; Federica Marchesi; Elena Turola; Stefano Fumagalli; Carlo Perego; Emanuela Parotto; Paola Vinci; Pietro Veglianese; Giovanna D'Amico; Claudia Verderio; Maria-Grazia De Simoni
Journal:  Neurotherapeutics       Date:  2014-07       Impact factor: 7.620

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.